Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo 200 vs Sinemet on Striatal 11C-Raclopride Binding in PD
NCT00562198Phase 2Terminated
- Sponsor
- Orion Corporation
- Start
- Jan 2008
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entacapone in Parkinson's disease (PD), sponsored by Orion Corporation. Started Jan 2008; status: terminated.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00562198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562198.